BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 33509214)

  • 1. Immuno-oncology: are TAM receptors in glioblastoma friends or foes?
    Zhou Y; Wang Y; Chen H; Xu Y; Luo Y; Deng Y; Zhang J; Shao A
    Cell Commun Signal; 2021 Jan; 19(1):11. PubMed ID: 33509214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological role of TAM receptors in the cancer microenvironment.
    Gadiyar V; Patel G; Davra V
    Int Rev Cell Mol Biol; 2020; 357():57-79. PubMed ID: 33234245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TAM kinases as regulators of cell death.
    Post SM; Andreeff M; DiNardo C; Khoury JD; Ruvolo PP
    Biochim Biophys Acta Mol Cell Res; 2021 May; 1868(6):118992. PubMed ID: 33647320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crosstalk Between Tumor-Associated Microglia/Macrophages and CD8-Positive T Cells Plays a Key Role in Glioblastoma.
    Tu S; Lin X; Qiu J; Zhou J; Wang H; Hu S; Yao Y; Wang Y; Deng Y; Zhou Y; Shao A
    Front Immunol; 2021; 12():650105. PubMed ID: 34394072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Requirement of Gamma-Carboxyglutamic Acid Modification and Phosphatidylserine Binding for the Activation of Tyro3, Axl, and Mertk Receptors by Growth Arrest-Specific 6.
    Geng K; Kumar S; Kimani SG; Kholodovych V; Kasikara C; Mizuno K; Sandiford O; Rameshwar P; Kotenko SV; Birge RB
    Front Immunol; 2017; 8():1521. PubMed ID: 29176978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TAM Receptor Inhibition-Implications for Cancer and the Immune System.
    Aehnlich P; Powell RM; Peeters MJW; Rahbech A; Thor Straten P
    Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33801886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual targeting of TAM receptors Tyro3, Axl, and MerTK: Role in tumors and the tumor immune microenvironment.
    Wang KH; Ding DC
    Tzu Chi Med J; 2021; 33(3):250-256. PubMed ID: 34386362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Harnessing the cross-talk between tumor cells and tumor-associated macrophages with a nano-drug for modulation of glioblastoma immune microenvironment.
    Li TF; Li K; Wang C; Liu X; Wen Y; Xu YH; Zhang Q; Zhao QY; Shao M; Li YZ; Han M; Komatsu N; Zhao L; Chen X
    J Control Release; 2017 Dec; 268():128-146. PubMed ID: 29051064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the TAM Receptors in Leukemia.
    Huey MG; Minson KA; Earp HS; DeRyckere D; Graham DK
    Cancers (Basel); 2016 Nov; 8(11):. PubMed ID: 27834816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential Interaction of Platelet-Derived Extracellular Vesicles With Circulating Immune Cells: Roles of TAM Receptors, CD11b, and Phosphatidylserine.
    Fendl B; Eichhorn T; Weiss R; Tripisciano C; Spittler A; Fischer MB; Weber V
    Front Immunol; 2018; 9():2797. PubMed ID: 30619243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pan-TAM Tyrosine Kinase Inhibitor BMS-777607 Enhances Anti-PD-1 mAb Efficacy in a Murine Model of Triple-Negative Breast Cancer.
    Kasikara C; Davra V; Calianese D; Geng K; Spires TE; Quigley M; Wichroski M; Sriram G; Suarez-Lopez L; Yaffe MB; Kotenko SV; De Lorenzo MS; Birge RB
    Cancer Res; 2019 May; 79(10):2669-2683. PubMed ID: 30877108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TAM receptors, Phosphatidylserine, inflammation, and Cancer.
    Burstyn-Cohen T; Maimon A
    Cell Commun Signal; 2019 Nov; 17(1):156. PubMed ID: 31775787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-Front War on Cancer-Targeting TAM Receptors in Solid Tumour Therapy.
    Mikolajczyk A; Mitula F; Popiel D; Kaminska B; Wieczorek M; Pieczykolan J
    Cancers (Basel); 2022 May; 14(10):. PubMed ID: 35626092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrinsic and Extrinsic Control of Hepatocellular Carcinoma by TAM Receptors.
    Hedrich V; Breitenecker K; Djerlek L; Ortmayr G; Mikulits W
    Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligand Activation of TAM Family Receptors-Implications for Tumor Biology and Therapeutic Response.
    Davra V; Kimani SG; Calianese D; Birge RB
    Cancers (Basel); 2016 Nov; 8(12):. PubMed ID: 27916840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TAM receptor signaling in immune homeostasis.
    Rothlin CV; Carrera-Silva EA; Bosurgi L; Ghosh S
    Annu Rev Immunol; 2015; 33():355-91. PubMed ID: 25594431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of TAM Family Receptors in Immune Cell Function: Implications for Cancer Therapy.
    Paolino M; Penninger JM
    Cancers (Basel); 2016 Oct; 8(10):. PubMed ID: 27775650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MerTK inhibition is a novel therapeutic approach for glioblastoma multiforme.
    Knubel KH; Pernu BM; Sufit A; Nelson S; Pierce AM; Keating AK
    Oncotarget; 2014 Mar; 5(5):1338-51. PubMed ID: 24658326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Multifaceted Roles of TAM Receptors during Viral Infection.
    Wang ZY; Wang PG; An J
    Virol Sin; 2021 Feb; 36(1):1-12. PubMed ID: 32720213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resolving inflammation by TAM receptor activation.
    Vago JP; Amaral FA; van de Loo FAJ
    Pharmacol Ther; 2021 Nov; 227():107893. PubMed ID: 33992683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.